✦ LIBER ✦

Erythropoiesis stimulating agents and other growth factors in low-risk MDS

✍ Scribed by Hellström-Lindberg, Eva; van de Loosdrecht, Arjan

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Risks and Benefits of Erythropoiesis-Sti

✍ Gernot Beutel; Arnold Ganser 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 207 KB

PCN86 DRUG UTILIZATION AND COST CONSIDER

✍ F Laliberte; RS Mckenzie; P Lefebvre; B Bookhart; F Vekeman; M Duh; CT Piech 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB

Lenalidomide in lower-risk myelodysplast

✍ David Sibon; Giovanna Cannas; Fiorenza Baracco; Thomas Prebet; Norbert Vey; Anne 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 140 KB

Hypoxia-inducible factor stabilizers and

✍ Simon Beuck; Wilhelm Schänzer; Mario Thevis 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 754 KB

O-010 Prognostic factors of response to

✍ Gardin, C.; Thepot, S.; Beyne-Rauzy, O.; Benabdelali, R.; Prebet, T.; Park, S.; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 70 KB

Erythropoiesis-stimulating agents in onc

✍ Glaspy, J; Crawford, J; Vansteenkiste, J; Henry, D; Rao, S; Bowers, P; Berlin, J 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 699 KB